Hypoglycemia Due to the Consumption of an Unidentified Compound for Weight Gain: A Case Report
,
Abstract
This case report highlights the adulteration of over-the-counter weight gain supplements with undeclared glyburide, culminating in a life-threatening episode of hypoglycemia in a healthy young adult. A previously healthy 23-year-old man was admitted to the emergency department on April 10, 2022, following a brief episode of unconsciousness. Upon arrival, his blood glucose was found to be 30 mg/dL. He reported having taken one herbal weight-gain tablet daily for the preceding three days. His blood glucose level quickly returned to normal after an intravenous dextrose infusion. Liquid chromatography-mass spectrometry (LC-MS) analysis of the tablets detected the presence of glyburide. The patient did not experience any further hypoglycemic episodes while being monitored and was discharged in stable condition after a four-day hospitalization. This case highlights the significant risk posed by undeclared sulfonylurea adulteration in unregulated herbal supplements, as well as the importance of implementing routine post-market quality control and toxicological screening to protect public health and prevent serious adverse events.
Vincente-Benito I, Ramírez-Durán MDV. Influence of Social Media Use on Body Image and Well-Being Among Adolescents and Young Adults: A Systematic Review. J Psychosoc Nurs Ment Health Serv. 2023;61(12):1-8.
Nagata JM, Hazzard VM, Ganson KT, Austin SB, Neumark-Sztainer D, Eisenberg ME. Muscle-building behaviors from adolescence to emerging adulthood: A prospective cohort study. Prev Med Rep. 2022;27:101778.
Pittler M, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev. 2005;6(2):93-111.
Onakpoya I, Davies L, Ernst E. Efficacy of herbal supplements containing Citrus aurantium and synephrine alkaloids for the management of overweight and obesity: a systematic review. Focus Altern Complement Ther. 2011;16(4):254-260.
Nagata JM, Hazzard VM, Ganson KT, Austin SB, Neumark-Sztainer D, Eisenberg ME. Muscle-building behaviors from adolescence to emerging adulthood: A prospective cohort study. Prev Med Rep. 2022;27:101778.
Yager Z, O’Dea JA. Relationships between body image, nutritional supplement use, and attitudes towards doping in sport among adolescent boys: implications for prevention programs. J Int Soc Sports Nutr. 2014;11(1):13.
Clarkson PM, Rawson ES. Nutritional supplements to increase muscle mass. Crit Rev Food Sci Nutr. 1999;39(4):317-328.
Saberi N, Akhgari M, Bahmanabadi L, Bazmi E, Mousavi Z. Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran. DARU. 2018;26:117-127.
Center for Food Safety and Applied Nutrition Adverse Event Reporting System USA: FDA; 2022 [Available from: https://open.fda.gov/data/caers/.
Piaggi P. Metabolic determinants of weight gain in humans. Obesity. 2019;27(5):691-699.
Cuda S, Censani M, Kharofa R, O'Hara V, Conroy R, Williams DR, et al. Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022. Obesity Pillars. 2022;4:100048.
Bahrke MS. Muscle Enhancement Substances and Strategies. 2007.
Administration USFaD. Caution: Bodybuilding Products Can Be Risky 2022 [Available from: https://www.fda.gov/consumers/consumer-updates/caution-bodybuilding-products-can-be-risky.
Steele IH, Pope HG, Jr., Kanayama G. Competitive Bodybuilding: Fitness, Pathology, or Both? Harv Rev Psychiatry. 2019;27(4):233-240.
Kanayama G, Pope Jr HG, Hudson JI. ‘Body image’drugs: A growing psychosomatic problem. Psychother Psychosom. 2001;70(2):61-65.
Farshidfar F, A Pinder M, B Myrie S. Creatine supplementation and skeletal muscle metabolism for building muscle mass-review of the potential mechanisms of action. Curr Protein Pept Sci. 2017;18(12):1273-1287.
Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RA. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes. 2018:427-438.
Provilus A, Abdallah M, McFarlane SI. Weight gain associated with antidiabetic medications. Clin Pract. 2011;8(2):113.
Velloso C. Regulation of muscle mass by growth hormone and IGF‐I. Br J Pharmacol. 2008;154(3):557-568.
Sketris I, Wheeler D, York S. Hypoglycemic coma induced by inadvertent administration of glyburide. Drug Intell Clin Pharm. 1984;18(2):142-143.
Malone M. Medications associated with weight gain. Ann Pharmacother. 2005;39(12):2046-2055.
Feldman JM. Glyburide: a second‐generation sulfonylurea hypoglycemic agent: history, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy. 1985;5(2):43-62.
Purohit DC, Vadalia J, Joshi H, Vegad UG. Rapid screening of undeclared hypoglycemics in counterfeit herbal antidiabetic products using HPTLC-MS. J Liq Chromatogr Relat Technol. 2022;45(5-8):100-106.
Alnaser RI, Alassaf FA, Abed MN. Adulteration of hypoglycemic products: the silent threat. Rom J Med Pract. 2023;18(4):202-205.
Valenzuela PL, Morales JS, Emanuele E, Pareja-Galeano H, Lucia A. Supplements with purported effects on muscle mass and strength. Eur J Nutr. 2019;58(8):2983-3008.
Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333-340.
| Files | ||
| Issue | Vol 13, No 3 (Summer 2025) | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/jpc.v13i3.20327 | |
| Keywords | ||
| Hypoglycemia | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
